Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > December 2011

« Previous month Next month »
News in brief

Happy holidays from

23-Dec-2011 - would like to wish all our readers a happy holiday

FDA researching gluten in drugs to help celiac disease patients

22-Dec-2011 - The US FDA is seeking information to help it protect celiac disease patients from pharma ingredients derived from wheat, barley, or rye.

Pall to buy ForteBio to build biopharma biz

22-Dec-2011 - Pall will buy US instrument maker ForteBio next year in a continuation of efforts to build its biomanufacturing technology offering.

Amgen and Watson team on biosimilars but agree to spare Amgen's drugs

22-Dec-2011 - Amgen has partnered with non-branded drugmaker Watson to develop biosimilar cancer drugs in a deal that goes some way towards protecting its own portfolio from generic competition.

Parexel discusses transdermal drug delivery techs

22-Dec-2011 - Electroporation is the wave of the future for transdermal drug delivery, according to Parexel’s Ravi Harapanhalli.

API Christmas everybody! - Top 10 API related developments in 2011

21-Dec-2011 - It’s been a busy year for API (active pharmaceutical ingredient) manufacturers with new facilities, cost pressures and regulatory developments all hitting the headlines.And it seems recent developments in HPAPIs (high...

Ranbaxy inks consent decree & prepares for $500m penalty

21-Dec-2011 - Ranbaxy has signed a consent decree with the US FDA and set aside $500m for penalty payments to settle its longstanding dispute.

News in brief

Eli Lilly collaborating with Arecor on stable protein formulations

21-Dec-2011 - Eli Lilly is collaborating with Arecor to develop stable aqueous or higher concentration formulations of protein and peptide drugs.

US scientists develop 'light up' delivery monitoring tech

21-Dec-2011 - Intracellular drug delivery testing could become quicker thanks to probes that "light up" when a medicine is delivered to a tumour.

DSM signs MoU with AIBN on biologics commercialisation

20-Dec-2011 - DSM Biologics will work with the Australian Institute for Bioengineering and Nanotechnology (AIBN) on the commercialisation of development-stage biologics projects.

China’s intermediates and API sector set growth, say researchers

20-Dec-2011 - China will keep its position as a leading API and intermediates supplier thanks to recovering global demand and the growth of the generic sector say market analysts.

News in brief

Eli Lilly expands collaboration to advance drug delivery tech

20-Dec-2011 - Eli Lilly has expanded its drug delivery partnership with Starpharma to include further in vivo studies and clinical testing.

SE Asia likely source of fake anti-malarials in Africa; study

20-Dec-2011 - Counterfeit anti-malarials containing the Viagra API were probably manufactured in Southeast Asia, researchers found.

News in brief

BASF hikes ethanolamine prices for second time in 2011

19-Dec-2011 - BASF has raised its prices for three ethanolamines (EOA), key intermediates in the production of a wide range of active pharmaceutical ingredients (API).

Drug-loaded lollipops could boost oral thrush compliance

19-Dec-2011 - Drug-loaded lollipops are the ideal dosage form to boost compliance in children with oral thrush, Indian researchers found.

News from Vertex, Pfizer and Prolong – People on the move

19-Dec-2011 - in-PharmaTechnologist presents its weekly round-up of the latest appointments within the pharmaceutical industry, including news from Vertex, Pfizer and Prolong.

Final rule adds manufacturing delay reporting requirements

19-Dec-2011 - Manufacturers of certain critical drugs must report production interruptions to the FDA under a new interim final rule.

GE wont say if turnkey bioplant partnership will cut prices for emerging nations

19-Dec-2011 - GE Healthcare wont say if its new turnkey biologics plant development service will offer Governments in emerging nations discounted rates.

Speed coating tech sales soaring, says Seppic

15-Dec-2011 - Seppic has seen a boom in demand for its new natural origin coating agents for pharmaceuticals, which can speed up production time by 50 per cent at lab stage.

News in brief

Trojan-horse nanoparticles used to deliver steroids to retina

15-Dec-2011 - Researchers have developed a Trojan-horse-style delivery system that transports steroids to the retina for the treatment of age-related macular degeneration and retinitis pigmentosa.

Drug quality treaty needed to raise standards, academics say

15-Dec-2011 - A treaty on medicine quality is needed to fix the major public health problem of substandard drugs, according to academics.

AMPAC posts Q4 loss as process improvement drags on profits

15-Dec-2011 - AMPAC posted a fourth quarter loss as process improvement difficulties offset rising demand for CNS and oncology ingredients.

Archimedes licenses Targit delivery tech to Pharmalink

14-Dec-2011 - UK-headquartered Archimedes Pharma has licensed its Targit drug delivery tech to Sweden’s Pharmalink AB for its candidate renal failure treatment, Nefecon.

GE and M+W team on plant and tech biologics production solution

14-Dec-2011 - GE Healthcare and M+W Group aim to capture a share of the rapidly expanding global biologics market with a new plant and manufacturing tech partnership.

EMA calls for Vistide recall over Ben Venue contamination fears

14-Dec-2011 - The EMA has recommended recalling a batch of Gilead’s Vistide manufactured by Ben Venue over particle contamination concerns.

« Previous month Next month »

Key Industry Events


Access all events listing

Our events, Shows & Conferences...